1-deoxynojirimycin has been researched along with Adenocarcinoma, Basal Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaney, WG; Hirota, M; Mogaki, M; Pour, PM | 1 |
Aubery, M; Codogno, P; Ogier-Denis, E; Sapin, C; Trugnan, G | 1 |
2 other study(ies) available for 1-deoxynojirimycin and Adenocarcinoma, Basal Cell
Article | Year |
---|---|
Modification of blood group A antigen expression in a pancreatic cancer cell line (PC-1) by inhibitors of N-glycan processing.
Topics: 1-Deoxynojirimycin; Adenocarcinoma; Amidohydrolases; Animals; Antigens, Neoplasm; Blood Group Antigens; Cricetinae; Electrophoresis, Polyacrylamide Gel; Galactosyltransferases; Glucosidases; Hexosaminidases; Immunohistochemistry; Lectins; Mesocricetus; Pancreatic Neoplasms; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Swainsonine; Tumor Cells, Cultured | 1992 |
Dual effect of 1-deoxymannojirimycin on the mannose uptake and on the N-glycan processing of the human colon cancer cell line HT-29.
Topics: 1-Deoxynojirimycin; Adenocarcinoma; alpha-Mannosidase; Cell Differentiation; Colonic Neoplasms; Glucosamine; Humans; Kinetics; Mannose; Mannosidases; Polysaccharides; Tumor Cells, Cultured | 1990 |